Vaccine gaps in Bundibugyo ebolavirus outbreak control and their implications for global public health preparedness and response
This study highlights the critical lack of licensed vaccines for Bundibugyo ebolavirus compared to Zaire ebolavirus, emphasizing that despite improved case fatality rates, outbreak control remains hindered by biomedical gaps and socioeconomic challenges, thereby necessitating sustained global investment in vaccine development and strengthened public health preparedness.